Supercomputing in the Life Sciences

Photo: Courtesy of Hewlett-Packard/Compaq The world's fastest supercomputer--Japan's Earth Simulator--occupies an area equivalent to four tennis courts on three floors. It contains 5,120 processors, 10 terabytes of memory, 700 terabytes of hard disk space, and it can perform 40 trillion floating point operations every second. The computer's performance exceeds that of the world's 18 next-fastest computers. It also cost an estimated $350 million (US). Japanese scientists use this supercomputer

Written byAmy Adams
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

The world's fastest supercomputer--Japan's Earth Simulator--occupies an area equivalent to four tennis courts on three floors. It contains 5,120 processors, 10 terabytes of memory, 700 terabytes of hard disk space, and it can perform 40 trillion floating point operations every second. The computer's performance exceeds that of the world's 18 next-fastest computers. It also cost an estimated $350 million (US).

Japanese scientists use this supercomputer to model global weather patterns, a monumentally complex problem. Though biological challenges may be less daunting, life scientists are finding uses for supercomputers, too. Researchers use them to search for disease-associated genes and potential drug targets, and to model protein folding, among other applications. Many investigators, in fact, have probably used a supercomputer without even being aware of it: Run a BLAST (basic local alignment search tool) search through the National Center for Biotechnology Information, and you are interacting--if only remotely--with a supercomputer.

Though the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies